Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10172935 Vaccination in newborns and infants

Patent 10172935 was granted and assigned to CureVac on January, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
CureVac
CureVac
Date Filed
March 22, 2017
Date of Patent
January 8, 2019
Patent Applicant
CureVac
CureVac
Patent Application Number
15466308
Patent Citations Received
‌
US Patent 11661634 Method for producing RNA
0
‌
US Patent 11667910 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
0
‌
US Patent 11760992 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
‌
US Patent 11761009 Artificial nucleic acid molecules for improved protein expression
‌
US Patent 11965000 Respiratory syncytial virus (RSV) vaccine
0
‌
US Patent 12109275 Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
0
‌
US Patent 11771653 Lipid nanoparticles for delivering mRNA vaccines
‌
US Patent 11771652 Lipid nanoparticles for delivering mRNA vaccines
‌
US Patent 11786590 Rotavirus vaccines
‌
US Patent 11433139 Peptide vaccines against interleukin-31
0
•••
Patent Inventor Names
Benjamin Petsch
0
Karl-Josef Kallen
0
Lothar Stitz
0
Margit Schnee
0
Thomas Kramps
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10172935
Patent Primary Examiner
‌
Janet L. Andres

Find more entities like US Patent 10172935 Vaccination in newborns and infants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.